DE3129719C2 - Pharmazeutisches Mittel - Google Patents

Pharmazeutisches Mittel

Info

Publication number
DE3129719C2
DE3129719C2 DE19813129719 DE3129719A DE3129719C2 DE 3129719 C2 DE3129719 C2 DE 3129719C2 DE 19813129719 DE19813129719 DE 19813129719 DE 3129719 A DE3129719 A DE 3129719A DE 3129719 C2 DE3129719 C2 DE 3129719C2
Authority
DE
Germany
Prior art keywords
tetrahydroquinoline
oximino
compound
diuretic
edema
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19813129719
Other languages
German (de)
English (en)
Other versions
DE3129719A1 (de
Inventor
Hiroshi Yokohama Kosuzume
Ei Tokyo Mochida
Haruo Funabashi Onishi
Yasuo Kawagushi Suzuki
Kazuo Tokyo Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Seiyaku Kk Tokyo Jp
Original Assignee
Mochida Seiyaku Kk Tokyo Jp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10327380A external-priority patent/JPS5728005A/ja
Priority claimed from JP3990981A external-priority patent/JPS57154167A/ja
Application filed by Mochida Seiyaku Kk Tokyo Jp filed Critical Mochida Seiyaku Kk Tokyo Jp
Publication of DE3129719A1 publication Critical patent/DE3129719A1/de
Application granted granted Critical
Publication of DE3129719C2 publication Critical patent/DE3129719C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19813129719 1980-07-28 1981-07-28 Pharmazeutisches Mittel Expired DE3129719C2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10327380A JPS5728005A (en) 1980-07-28 1980-07-28 Pharmaceutical composition having diuretic, hypotensive and antihydropic activity
JP3990981A JPS57154167A (en) 1981-03-19 1981-03-19 Pharmaceutical composition having diuretic, hypotensive and antihydropic activity

Publications (2)

Publication Number Publication Date
DE3129719A1 DE3129719A1 (de) 1982-03-18
DE3129719C2 true DE3129719C2 (de) 1984-04-26

Family

ID=26379310

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19813129719 Expired DE3129719C2 (de) 1980-07-28 1981-07-28 Pharmazeutisches Mittel

Country Status (3)

Country Link
DE (1) DE3129719C2 (fr)
FR (1) FR2487196A1 (fr)
GB (1) GB2081091B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839368A (en) * 1986-05-02 1989-06-13 Mochida Pharmaceutical Co., Ltd. 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
JP2602037B2 (ja) * 1987-10-31 1997-04-23 持田製薬株式会社 １−アシル−２，３−ジヒドロ−４（１ｈ）−キノリノン−４−オキシム誘導体、その製法およびそれらを主成分とする利尿、降圧、抗浮腫および腹水除去用医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3406176A (en) * 1964-08-24 1968-10-15 Sterling Drug Inc 7-halo-4-carbamylimino-1, 4-dihydroquinolines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT

Also Published As

Publication number Publication date
FR2487196A1 (fr) 1982-01-29
GB2081091A (en) 1982-02-17
DE3129719A1 (de) 1982-03-18
GB2081091B (en) 1984-03-07
FR2487196B1 (fr) 1984-12-28

Similar Documents

Publication Publication Date Title
DE2952279A1 (de) Neue 2-acylaminomethyl-1,4-benzodiazepine und deren salze sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0276803B1 (fr) (Hydroxy-4 ditertiobutyl-3,5 benzoyl)-1 homopipérazine, ses dérivés divers, procédés pour la préparation de ces composés, médicaments les contenant et leur application
EP0104423B1 (fr) Nitro-2-éthènediamines-1,1, procédé pour leur préparation ainsi que leur application comme médicaments
AT391864B (de) Verfahren zur herstellung von neuen 5-pyrimidincarboxamiden und deren additionssalzen
DE2921660A1 (de) 5-nitroimidazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende antiprotozoen-mittel
DE3129719C2 (de) Pharmazeutisches Mittel
DE2549568C3 (de) 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE2535599C2 (de) Substituierte Zimtsäureamide, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten
DE2413125C2 (de) Indolylacetylaminosäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneipräparate
DE2427272C3 (de) 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
DE2711149C3 (de) N-Substituierte[4-Chlor-6-(23-xylidino)-2· pyrimidinyl- thio] essigsäureamide sowie Verfahren zu deren Herstellung
DE3342999A1 (de) Schwefelhaltige benzylidenderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3438244A1 (de) 4-chlor-furo-(3,4-c)-pyridinderivate, verfahren zu ihrer herstellung und arzneimittel mit einem gehalt an diesen verbindungen
EP0068240B1 (fr) Acylaminométhyl-2-benzodiazépines-1,4, leur préparation et produits intermédiaires et produit pharmaceutiques qui les contiennent
DE1934392C3 (de) Neue 2-Pyridylthioamide und Verfahren zu ihrer Herstellung
EP0088323B1 (fr) Amides d'acides imidazothiadiazolealcanecarboxyliques, produits intermédiaires pour leur fabrication, leur fabrication et leur application en médicaments
DE3414049C2 (fr)
DE2636866A1 (de) Neue phenothiazinderivate und deren herstellung
DE1906322A1 (de) Neue alpha-Alkyl-5-hydroxytryptophanester
DE2629756C2 (fr)
DE1645901C3 (de) gamma-(4-Alkylp!peridino)-p-fluorbutyrophenone und Verfahren zu ihrer Herstellung
DE2050092C3 (de) Chinazolondiurethane, Verfahren zu ihrer Herstellung sowie Arzneimittel, die diese Verbindungen enthalten
DE1957769B2 (de) 4,6-Diamino-1 ^-dihydro-2^-dimethyl-133-triazin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate
DE2027577C3 (de) Glyzirrhetinsäureester, ihre Herstellung und diese enthaltende, pharmazeutische Zubereitungen
DE2116252A1 (de) Dihydrotnazine, ihre Saureadditions salze und N Acyldenvate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen als Wirkstoffe ent halten

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee